Karin Hägerbrand

892 total citations · 1 hit paper
16 papers, 667 citations indexed

About

Karin Hägerbrand is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Karin Hägerbrand has authored 16 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 10 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Karin Hägerbrand's work include Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Karin Hägerbrand is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Karin Hägerbrand collaborates with scholars based in Sweden, Denmark and France. Karin Hägerbrand's co-authors include William W. Agace, Emma K. Persson, Aymeric Rivollier, Sigurður Guðjónsson, Knut Kotarsky, Ulf Håkansson, Monika Semmrich, Boris Reizis, Heli Uronen‐Hansson and Jan Marsal and has published in prestigious journals such as SHILAP Revista de lepidopterología, Immunity and The Journal of Immunology.

In The Last Decade

Karin Hägerbrand

14 papers receiving 666 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IRF4 Transcription-Factor-Dependent CD103+CD11b+ Dendritic Cells Drive Mucosal T Helper 17 Cell Differentiation

2013 453 citations Emma K. Persson, Heli Uronen‐Hansson et al. Immunity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karin Hägerbrand Sweden	8	550	156	117	40	39	16	667
Peter Bergqvist Sweden	9	369 0.7×	69 0.4×	138 1.2×	26 0.7×	38 1.0×	10	504
Katherine Miles United Kingdom	10	547 1.0×	45 0.3×	132 1.1×	48 1.2×	42 1.1×	13	716
Katina Schinnerling Chile	15	329 0.6×	59 0.4×	109 0.9×	83 2.1×	34 0.9×	28	734
Masahiro Onji Japan	12	460 0.8×	100 0.6×	201 1.7×	97 2.4×	15 0.4×	20	711
Victoria L. Wilkinson United States	10	452 0.8×	148 0.9×	98 0.8×	55 1.4×	53 1.4×	11	650
Magali de Heusch Belgium	11	559 1.0×	86 0.6×	85 0.7×	62 1.6×	9 0.2×	15	674
Tae Jin Yun United States	8	326 0.6×	59 0.4×	116 1.0×	41 1.0×	10 0.3×	11	454
Adam Laing United Kingdom	7	655 1.2×	173 1.1×	163 1.4×	125 3.1×	23 0.6×	11	844
Jeff Hooley United States	7	280 0.5×	71 0.5×	124 1.1×	59 1.5×	45 1.2×	15	455
Jessica A. Yang United States	7	861 1.6×	164 1.1×	93 0.8×	58 1.4×	10 0.3×	8	980

Countries citing papers authored by Karin Hägerbrand

Since Specialization

Citations

This map shows the geographic impact of Karin Hägerbrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Hägerbrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Hägerbrand more than expected).

Fields of papers citing papers by Karin Hägerbrand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Hägerbrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Hägerbrand. The network helps show where Karin Hägerbrand may publish in the future.

Co-authorship network of co-authors of Karin Hägerbrand

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Hägerbrand. A scholar is included among the top collaborators of Karin Hägerbrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Hägerbrand. Karin Hägerbrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Hägerbrand, Karin, Laura A. Varas, Anette Gjörloff Wingren, et al.. (2025). Antigenic peptide delivery to antigen-presenting cells using a CD40-coiled coil affinity-based platform. Drug Delivery. 32(1). 2486340–2486340. 1 indexed citations

Hägerbrand, Karin, et al.. (2024). Next-generation CD40 agonists for cancer immunotherapy. Expert Opinion on Biological Therapy. 24(5). 351–363. 8 indexed citations

Rosén, Anna, et al.. (2024). RUBY® – a tetravalent (2+2) bispecific antibody format with excellent functionality and IgG-like stability, pharmacology and developability properties. mAbs. 16(1). 2330113–2330113. 2 indexed citations

Lilljebjörn, Henrik, Pontus Eriksson, Gottfrid Sjödahl, et al.. (2024). Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes. Cells. 13(11). 926–926. 2 indexed citations

Coaña, Yago Pico de, et al.. (2023). Early Pharmacodynamic Changes Measured Using RNA Sequencing of Peripheral Blood from Patients in a Phase I Study with Mitazalimab, a Potent CD40 Agonistic Monoclonal Antibody. Cells. 12(19). 2365–2365. 4 indexed citations

Lilljebjörn, Henrik, Carl Sandén, Alar Aab, et al.. (2022). Transcriptional profiling demonstrates altered characteristics of CD8⁺ cytotoxic T‐cells and regulatory T‐cells in TP53‐mutated acute myeloid leukemia. Cancer Medicine. 11(15). 3023–3032. 10 indexed citations

Hägerbrand, Karin & Peter Ellmark. (2022). Kick-starting tumor specific T cell priming & targeting the tumor microenvironment using CD40 targeting bispecific antibodies. 3(4). 173–180. 1 indexed citations

Deronic, Adnan, et al.. (2021). Rationale and clinical development of CD40 agonistic antibodies for cancer immunotherapy. Expert Opinion on Biological Therapy. 21(12). 1635–1646. 22 indexed citations

Hägerbrand, Karin, Laura von Schantz, Laura A. Varas, et al.. (2021). 751 Neo-X-Prime bispecific antibodies targeting CD40 and tumor antigens promote cross-presentation of tumor exosome-derived neoantigen and induce superior anti-tumor responses compared to CD40 mAb. SHILAP Revista de lepidopterología. A785–A785.

10.

Ellmark, Peter, Karin Hägerbrand, Laura von Schantz, et al.. (2020). 858 A bispecific antibody targeting CD40 and EpCAM induces superior anti-tumor effects compared to the combination of the monospecific antibodies. SHILAP Revista de lepidopterología. A511.1–A511. 4 indexed citations

11.

Kvarnhammar, Anne Månsson, Niina Veitonmäki, Karin Hägerbrand, et al.. (2019). The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation. Journal for ImmunoTherapy of Cancer. 7(1). 103–103. 89 indexed citations

12.

Veitonmäki, Niina, Karin Hägerbrand, Anna Rosén, et al.. (2018). Abstract 3623: The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation. Cancer Research. 78(13_Supplement). 3623–3623.

13.

Flores‐Langarica, Adriana, Katarzyna M. Luda, Emma K. Persson, et al.. (2017). CD103+CD11b+ mucosal classical dendritic cells initiate long-term switched antibody responses to flagellin. Mucosal Immunology. 11(3). 681–692. 26 indexed citations

14.

Hägerbrand, Karin, et al.. (2016). IL‐18Rα‐deficient CD4⁺ T cells induce intestinal inflammation in the CD45RB^hi transfer model of colitis despite impaired innate responsiveness. European Journal of Immunology. 46(6). 1371–1382. 9 indexed citations

15.

Hägerbrand, Karin, et al.. (2015). MyD88 Signaling Regulates Steady-State Migration of Intestinal CD103+ Dendritic Cells Independently of TNF-α and the Gut Microbiota. The Journal of Immunology. 195(6). 2888–2899. 36 indexed citations

16.

Persson, Emma K., Heli Uronen‐Hansson, Monika Semmrich, et al.. (2013). IRF4 Transcription-Factor-Dependent CD103+CD11b+ Dendritic Cells Drive Mucosal T Helper 17 Cell Differentiation. Immunity. 38(5). 958–969. 453 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact